HealthEquity, Inc. Expected to Earn Q3 2025 Earnings of $0.50 Per Share (NASDAQ:HQY)

HealthEquity, Inc. (NASDAQ:HQY) – Research analysts at Barrington Research decreased their Q3 2025 earnings estimates for HealthEquity in a research note issued on Wednesday, September 4th. Barrington Research analyst A. Paris now forecasts that the company will earn $0.50 per share for the quarter, down from their previous forecast of $0.52. Barrington Research currently has a “Outperform” rating and a $105.00 target price on the stock. The consensus estimate for HealthEquity’s current full-year earnings is $2.12 per share. Barrington Research also issued estimates for HealthEquity’s Q4 2025 earnings at $0.53 EPS.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Monday, June 3rd. The company reported $0.55 earnings per share for the quarter, beating the consensus estimate of $0.47 by $0.08. The company had revenue of $287.60 million during the quarter, compared to the consensus estimate of $278.78 million. HealthEquity had a return on equity of 7.77% and a net margin of 7.71%.

A number of other analysts also recently commented on HQY. JMP Securities restated a “market outperform” rating and set a $105.00 price objective on shares of HealthEquity in a report on Wednesday. Raymond James raised their price objective on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Friday, June 7th. Deutsche Bank Aktiengesellschaft boosted their target price on HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday. Royal Bank of Canada restated an “outperform” rating and issued a $92.00 price target on shares of HealthEquity in a report on Wednesday. Finally, Bank of America decreased their price objective on shares of HealthEquity from $105.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday. One research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $103.83.

HealthEquity Stock Down 3.8 %

HQY opened at $79.49 on Friday. HealthEquity has a 12 month low of $61.81 and a 12 month high of $88.26. The business has a 50-day moving average of $77.23 and a two-hundred day moving average of $79.70. The company has a debt-to-equity ratio of 0.44, a current ratio of 4.39 and a quick ratio of 4.39. The stock has a market capitalization of $6.92 billion, a price-to-earnings ratio of 86.40, a price-to-earnings-growth ratio of 1.34 and a beta of 0.52.

Insider Buying and Selling at HealthEquity

In related news, Vice Chairman Stephen Neeleman sold 35,000 shares of the firm’s stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $79.86, for a total transaction of $2,795,100.00. Following the transaction, the insider now owns 89,769 shares of the company’s stock, valued at $7,168,952.34. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other news, Vice Chairman Stephen Neeleman sold 35,000 shares of the stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $79.86, for a total transaction of $2,795,100.00. Following the transaction, the insider now owns 89,769 shares of the company’s stock, valued at approximately $7,168,952.34. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Jon Kessler sold 32,326 shares of the business’s stock in a transaction that occurred on Monday, June 24th. The stock was sold at an average price of $82.83, for a total value of $2,677,562.58. Following the completion of the sale, the chief executive officer now owns 232,176 shares of the company’s stock, valued at $19,231,138.08. The disclosure for this sale can be found here. Insiders have sold 75,031 shares of company stock worth $6,103,625 over the last 90 days. 2.20% of the stock is currently owned by corporate insiders.

Institutional Trading of HealthEquity

Several large investors have recently modified their holdings of HQY. Vanguard Group Inc. lifted its position in HealthEquity by 1.7% during the 1st quarter. Vanguard Group Inc. now owns 8,768,632 shares of the company’s stock worth $715,783,000 after acquiring an additional 149,133 shares during the last quarter. Wasatch Advisors LP lifted its position in shares of HealthEquity by 8.3% during the 1st quarter. Wasatch Advisors LP now owns 7,409,080 shares of the company’s stock worth $604,803,000 after purchasing an additional 569,249 shares during the last quarter. Motley Fool Asset Management LLC grew its holdings in HealthEquity by 3,001.0% in the 1st quarter. Motley Fool Asset Management LLC now owns 3,762,064 shares of the company’s stock valued at $307,097,000 after buying an additional 3,640,748 shares during the last quarter. Clearbridge Investments LLC grew its holdings in HealthEquity by 1.9% in the 2nd quarter. Clearbridge Investments LLC now owns 2,377,204 shares of the company’s stock valued at $204,915,000 after buying an additional 43,491 shares during the last quarter. Finally, Mackenzie Financial Corp grew its holdings in HealthEquity by 16.0% in the 2nd quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock valued at $203,822,000 after buying an additional 325,906 shares during the last quarter. 99.55% of the stock is owned by institutional investors.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.